Quick question:
What happens when a company raises full-year guidance... but its stock still trades under $10?
Usually, it means the market hasn't caught up yet. And that gap? That's where the money is made.
Right now, three companies just raised their 2025 guidance, yet they're all still priced under $10. This disconnect won't last long.
Consider what just happened:
-
A payments platform just raised 2025 revenue guidance to over $1 billion
-
A pharma company boosted its product sales forecast to $270-275 million
-
An Asian tech giant lifted adjusted EBITDA targets to nearly half a billion
These aren't speculative plays. These are companies already executing, already growing, already raising guidance. Yet somehow they're still priced like lottery tickets.
Wall Street analysts see it. They've assigned price targets suggesting 30% to 100% upside from current levels. But most retail investors? They're too busy chasing yesterday's winners to notice today's opportunity.
The window is closing. Once these stocks break $10, the easy money is gone.
Click here to get your free copy of this report
Tomorrow these could be $15 stocks. Today they're still under $10.
0 Response to "These 3 stocks just raised guidance (still under $10)"
Post a Comment